Angiotensin converting enzyme inhibitors in the elderly.
- 17 October 1987
- Vol. 295 (6604) , 943-944
- https://doi.org/10.1136/bmj.295.6604.943
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987
- CAPTOPRIL VERSUS HYDROCHLOROTHIAZIDE/ TRIAMTERENE IN MILD-TO-MODERATE HYPERTENSION IN THE ELDERLYThe Lancet, 1986
- The Effects of Antihypertensive Therapy on the Quality of LifeNew England Journal of Medicine, 1986
- Severe hypotension after first dose of enalapril in heart failure.BMJ, 1985
- Initial dose of enalapril in hypertension.BMJ, 1985
- ANGIOTENSIN-CONVERTING ENZYME INHIBITORS: PAST, PRESENT, AND BRIGHT FUTUREThe Lancet, 1985
- Age and cardiovascular response adaptation. Determinants of an antihypertensive treatment concept primarily based on beta-blockers and calcium entry blockers.Hypertension, 1983
- Factors related to first dose hypotensive effect of captopril: prediction and treatment.BMJ, 1983
- Effects of an angiotensin-converting enzyme inhibitor (captopril) on blood pressure in anephric subjects.BMJ, 1980
- CAPTOPRIL IN THE TREATMENT OF CLINICAL HYPERTENSION AND CARDIAC FAILUREThe Lancet, 1979